ARTICLE | Company News
Affectis, Grupo Uriach deal
January 29, 2007 8:00 AM UTC
Grupo Uriach's Palau Pharma subsidiary granted Affectis an exclusive worldwide license to cimicoxib to treat all CNS indications except pain. Affectis will develop the COX-2 inhibitor to treat depres...